Eli Lilly

YTD

ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.

CEO

David A. Ricks

CEODavid A. Ricks

Employees

47,000

Employees47,000

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1876

Founded1876

Employees

47,000

Employees47,000

LLY Key Statistics

Market cap

732.45B

Market cap732.45B

Price-Earnings ratio

64.67

Price-Earnings ratio64.67

Dividend yield

0.72%

Dividend yield0.72%

Average volume

2.88M

Average volume2.88M

High today

$781.15

High today$781.15

Low today

$762.40

Low today$762.40

Open price

$779.68

Open price$779.68

Volume

2.58M

Volume2.58M

52 Week high

$972.53

52 Week high$972.53

52 Week low

$677.09

52 Week low$677.09

LLY News

Simply Wall St 21m

Eli Lilly and Company is a favorite amongst institutional investors who own 89%

Advertisement Key Insights Significantly high institutional ownership implies Eli Lilly's stock price is sensitive to their trading actions A total of 10 inv...

TipRanks 1h

Positive Outlook for Eli Lilly & Co Driven by Strong Product Performance and International Growth

Mohit Bansal, an analyst from Wells Fargo, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,100.00. Don’t Miss...

TipRanks 16h

Eli Lilly Lowers Cost of Weight-Loss Drug as Insurance Coverage Remains Elusive

Eli Lilly (LLY) continues to lower prices for its popular weight-loss drug Zepbound. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at...

Analyst ratings

83%

of 30 ratings

Buy

83.3%

Hold

10%

Sell

6.7%

More LLY News

TipRanks 4d

Eli Lilly and Regeneron: Exploring New Frontiers in Obesity Treatment

Eli Lilly And Company ((LLY)), Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Tak...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…